A broad analysis of resistance development in the malaria parasite

被引：93

作者：

Corey, Victoria C. ^{[1
]}

Lukens, Amanda K. ^{[2
,3
]}

Istvan, Eva S. ^{[4
]}

Lee, Marcus C. S. ^{[5
]}

Franco, Virginia ^{[6
]}

Magistrado, Pamela ^{[2
]}

Coburn-Flynn, Olivia ^{[5
]}

Sakata-Kato, Tomoyo ^{[2
]}

Fuchs, Olivia ^{[1
]}

Gnadig, Nina F. ^{[5
]}

Goldgof, Greg ^{[1
]}

Linares, Maria ^{[6
]}

Gomez-Lorenzo, Maria G. ^{[6
]}

De Cozar, Cristina ^{[6
]}

Jose Lafuente-Monasterio, Maria ^{[6
]}

Prats, Sara ^{[6
]}

Meister, Stephan ^{[1
]}

Tanaseichuk, Olga ^{[7
]}

Wree, Melanie ^{[1
]}

Zhou, Yingyao ^{[7
]}

Willis, Paul A. ^{[8
]}

Gamo, Francisco-Javier ^{[6
]}

Goldberg, Daniel E. ^{[4
]}

Fidock, David A. ^{[5
]}

Wirth, Dyann F. ^{[2
,3
]}

Winzeler, Elizabeth A. ^{[1
]}

机构：

[1] Univ Calif San Diego, Sch Med, Dept Pediat, 9500 Gilman Dr 0741, La Jolla, CA 92093 USA

[2] Harvard Univ, TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA

[3] Broad Inst, Program Infect Dis, 415 Main St, Cambridge, MA 02142 USA

[4] Washington Univ, Sch Med, Dept Med & Microbiol, St Louis, MO 63110 USA

[5] Columbia Univ Coll Phys & Surg, Dept Microbiol & Immunol, 630 W 168th St, New York, NY 10032 USA

[6] GlaxoSmithKline, Malaria DPU, Tres Cantos Med Dev Campus,Severo Ochoa 2, Madrid 28760, Spain

[7] Novartis Res Fdn, Genom Inst, 10675 John J Hopkins Dr, San Diego, CA 92121 USA

[8] Med Malaria Venture, POB 1826,20 Route Prebois, CH-1215 Geneva 15, Switzerland

来源：

NATURE COMMUNICATIONS | 2016年 / 7卷

关键词：

PLASMODIUM-FALCIPARUM; ARTEMISININ RESISTANCE; CLINICAL CANDIDATE; ANTIMALARIAL-DRUGS; DISCOVERY; VALIDATION; MUTATIONS; DIVERSITY; INVITRO; SITE;

D O I：

10.1038/ncomms11901

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Microbial resistance to chemotherapy has caused countless deaths where malaria is endemic. Chemotherapy may fail either due to pre-existing resistance or evolution of drug-resistant parasites. Here we use a diverse set of antimalarial compounds to investigate the acquisition of drug resistance and the degree of cross-resistance against common resistance alleles. We assess cross-resistance using a set of 15 parasite lines carrying resistance-conferring alleles in pfatp4, cytochrome bc(1), pfcarl, pfdhod, pfcrt, pfmdr, pfdhfr, cytoplasmic prolyl t-RNA synthetase or hsp90. Subsequently, we assess whether resistant parasites can be obtained after several rounds of drug selection. Twenty-three of the 48 in vitro selections result in resistant parasites, with time to resistance onset ranging from 15 to 300 days. Our data indicate that pre-existing resistance may not be a major hurdle for novel-target antimalarial candidates, and focusing our attention on fast-killing compounds may result in a slower onset of clinical resistance.

引用

页数：9

共 50 条

[1] Artemisinin Resistance and Stage Dependency of Parasite Clearance in Falciparum Malaria
Intharabut, Benjamas
Kingston, Hugh W.
Srinamon, Ketsanee
Ashley, Elizabeth A.
Imwong, Mallika
Dhorda, Mehul
Woodrow, Charles
Stepniewska, Kasia
Silamut, Kamolrat
Day, Nicholas P. J.
Dondorp, Arjen M.
White, Nicholas J.
Faiz, Abul
Lim, Pharath
Fairhurst, Rick
Nguon, Chea
Borrmann, Steffen
Mayxay, Mayfong
Htut, Ye
Mokuolu, Olugbenga A.
Onyamboko, Marie
Fanello, Caterina
Nosten, Francois
Pukrittayakamee, Sasithon
Tripura, Rupam
Tran Tinh Hien
JOURNAL OF INFECTIOUS DISEASES, 2019, 219 (09) : 1483 - 1489
[2] Malaria parasite clearance
White, Nicholas J.
MALARIA JOURNAL, 2017, 16
[3] Malaria parasite genome scan: insights into antimalarial resistance
Gupta, Bhavna
Awasthi, Gauri
Das, Aparup
PARASITOLOGY RESEARCH, 2010, 107 (02) : 495 - 499
[4] Within-host competition and drug resistance in the human malaria parasite Plasmodium falciparum
Bushman, Mary
Morton, Lindsay
Duah, Nancy
Quashie, Neils
Abuaku, Benjamin
Koram, Kwadwo A.
Dimbu, Pedro Rafael
Plucinski, Mateusz
Gutman, Julie
Lyaruu, Peter
Kachur, S. Patrick
de Roode, Jacobus C.
Udhayakumar, Venkatachalam
PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2016, 283 (1826)
[5] Genomic analysis of single nucleotide polymorphisms in malaria parasite drug targets
Gill, Jasmita
Sharma, Amit
PARASITES & VECTORS, 2022, 15 (01)
[6] Saquinavir Inhibits the Malaria Parasite's Chloroquine Resistance Transporter
Martin, Rowena E.
Butterworth, Alice S.
Gardiner, Donald L.
Kirk, Kiaran
McCarthy, James S.
Skinner-Adams, Tina S.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (05) : 2283 - 2289
[7] Stepwise acquisition of pyrimethamine resistance in the malaria parasite
Lozovsky, Elena R.
Chookajorn, Thanat
Brown, Kyle M.
Imwong, Mallika
Shaw, Philip J.
Kamchonwongpaisan, Sumalee
Neafsey, Daniel E.
Weinreich, Daniel M.
Hartl, Daniel L.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (29) : 12025 - 12030
[8] Mechanisms of resistance to the partner drugs of artemisinin in the malaria parasite
Martin, Rowena E.
Shafik, Sarah H.
Richards, Sashika N.
CURRENT OPINION IN PHARMACOLOGY, 2018, 42 : 71 - 80
[9] An Alternative Autophagy-Related Mechanism of Chloroquine Drug Resistance in the Malaria Parasite
Kamil, Mohd
Atmaca, Habibe N.
Unal, Sinem
Kina, Umit Y.
Burak, Pinar
Deveci, Gozde
Yilmaz, Ilknur
Aly, Ahmed S., I
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2022, 66 (12)
[10] A Class of Tricyclic Compounds Blocking Malaria Parasite Oocyst Development and Transmission
Eastman, Richard T.
Pattaradilokrat, Sittiporn
Raj, Dipak K.
Dixit, Saurabh
Deng, Bingbing
Miura, Kazutoyo
Yuan, Jing
Tanaka, Takeshi Q.
Johnson, Ronald L.
Jiang, Hongying
Huang, Ruili
Williamson, Kim C.
Lambert, Lynn E.
Long, Carole
Austin, Christopher P.
Wu, Yimin
Su, Xin-zhuan
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (01) : 425 - 435

← 1 2 3 4 5 →